about
Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesisUltradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instabilityCyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.Integrative analysis of hereditary nonpolyposis colorectal cancer: the contribution of allele-specific expression and other assays to diagnostic algorithms.Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialEffects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsComparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group.Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancerPrevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.Peutz-Jeghers syndrome: a systematic review and recommendations for management.Is laparoscopic surgery an option to support prophylactic colectomy in adolescent patients with Familial Adenomatous Polyposis (FAP)?Wireless capsule endoscopy in adolescents with familial adenomatous polyposis.A proposed staging system and stage-specific interventions for familial adenomatous polyposisFamily history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study.Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells.Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databaseParity and breast cancer: confirmed evidence of an effect on age at diagnosis.Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations.Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.Human leukocyte antigen class II genes and Helicobacter pylori infection: does genotype overwhelm environmental exposure?Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.Different genetic features associated with colon and rectal carcinogenesis.Predictors of metachronous colorectal neoplasms in sporadic adenoma patients.Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis.Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes.Comment on Koskenvuo et al.: Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis.BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis.
P50
Q28269118-4CEA088F-10A1-4197-9BDE-5410E9E065B2Q33522197-FFAFDC5C-81CD-4EBC-B526-FB55958AFC3BQ34582442-A39ACD8C-4C1D-4DE1-96C7-71FE04AFAFC4Q34732921-6D51FC31-ADE7-4880-8C4B-DE547E907581Q34901055-8176AF51-E476-4618-AB0E-ACBBA69080F5Q34974010-076719DC-0B60-47FB-B3A4-1672127A2761Q35053925-56AC5048-C0F6-42BC-8749-7584F41B3FEAQ35627411-654EAD45-507D-4FE1-92D6-8D1D8BCFA163Q35847666-C9510C6C-11DD-45E9-AA80-57ACF71D7B1BQ36393854-0F18DEDA-4FE2-410B-8D01-4E2E33853F2AQ36746989-82E4A696-0CBE-4CA9-BB4E-F7D204E363C8Q36824964-83E00710-05D9-412D-BB96-2A19A2D61C64Q36887649-CD084E94-BCE0-485D-8B27-EA9CCC60593FQ36953347-EC8D86E3-C6B4-4A9B-99E0-08E7A342DD2FQ36980711-C6A321E7-2D2B-4C13-90EE-2B342C4F2440Q37103047-769319B6-BA77-49F8-BE42-9E48AD8E650EQ37767967-E9DC1BA2-500C-4FBC-BAA7-5B8E56F2AECDQ37989415-D9381E14-73FB-4C98-AB04-4767DD1839D0Q38556284-DF4834FE-0E26-488F-976B-96836EF12003Q38697381-445F67A7-CA1E-4061-B7F8-5A95F49EA915Q39709329-E2C7939C-63C4-4366-B892-736433611D72Q40221041-F80EAB95-EC53-411F-9889-DFF47B5BB9A2Q40318946-857C4DD6-9021-42EE-B959-7239ED04D114Q40719336-44D06E42-756B-4E82-881B-38370FEE5A63Q41627095-DE8B7635-6163-4A48-AE32-0AC657A64047Q42374502-468623E6-ABEC-4564-BA5D-1C8261523B27Q42690216-855AE965-D5EB-458A-BFED-9F375E8F62FFQ44422800-B3E74A2C-9B79-4C3F-8D1F-F828C8D6D0AAQ44551715-967DC2A9-C11D-4E59-A7E5-6236DCBC256FQ44785975-2344E876-83E6-45D1-B4C5-80BCB76C4B86Q44813939-A7623A03-20A1-4049-BAE9-D78DBA9CE9ECQ46538007-E1F056D1-EA10-40BB-B24F-6C7E0959428FQ47290195-50441F48-D7EA-42AD-9749-DB319642023DQ47997871-1970CDE8-DAEF-4903-B323-45AAE4C3A534Q51163895-7FD18138-8A53-40A5-8A8E-37D3342A0701Q51624037-413AB727-BB81-45E3-9912-406A39A8512EQ54193595-6B2438D9-6C75-40AA-BC09-6F696E9B0A6FQ54284799-ED8F41E8-653A-4225-9C33-15127B26A363Q54334013-989731B3-8553-49B9-ADC1-A2B1C3F0A34AQ54374432-B569B378-295F-418F-BA90-73CE07992251
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
L Bertario
@ast
L Bertario
@en
L Bertario
@es
L Bertario
@nl
L Bertario
@sl
type
label
L Bertario
@ast
L Bertario
@en
L Bertario
@es
L Bertario
@nl
L Bertario
@sl
altLabel
Lucio Bertario
@en
prefLabel
L Bertario
@ast
L Bertario
@en
L Bertario
@es
L Bertario
@nl
L Bertario
@sl
P106
P1153
7005117548
P31
P496
0000-0001-5653-1431